Emami Limited has made available the audio recording of its conference call with analysts and investors, providing insights into the company’s unaudited financial performance for the quarter ended June 30, 2026. The call took place on August 4, 2026, following the declaration of both standalone and consolidated results for Q1FY27. This disclosure ensures transparency and allows stakeholders to review management’s commentary on the latest financial outcomes directly.

The announcement was filed pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Emami Limited submitted the link to the audio recording to both the National Stock Exchange of India Ltd. and BSE Limited on August 4, 2026. The filing was signed by Ravi Varma, Company Secretary & Compliance Officer (Membership No: F9531), confirming the regulatory compliance of the disclosure.

Key Details of the Disclosure

The audio recording is hosted on the company’s investor relations website. Investors seeking to understand the drivers behind the quarterly performance, including operational highlights and financial metrics, can access the recording through the provided link. This step is part of standard corporate governance practices, ensuring that all market participants have equal access to material information discussed during the earnings briefing.

No specific financial figures such as net profit, revenue, or EBITDA were included in this particular filing, as it serves solely as a pointer to the audio resource. However, the availability of the call transcript allows for a deeper dive into the strategic initiatives and market conditions affecting Emami Limited during the period. Stakeholders are advised to refer to the separate financial results filings for detailed numerical data.

What the Numbers Show

While this specific document does not contain quantitative financial data, the timing of the call immediately post-result declaration indicates a focus on clarifying the unaudited standalone and consolidated outcomes for Q1FY27. The emphasis on compliance with Regulation 30 underscores the company's adherence to listing obligations, ensuring that the narrative surrounding the financial results is accessible to all investors simultaneously.

Emami Limited reported resilient top-line growth in its first quarter of FY27, with consolidated revenue from operations rising 15% year-on-year to ₹1,039 crore. The performance was anchored by a robust 20% growth in the Domestic Business segment, which offset a 12% decline in International Business caused by geopolitical disruptions in West Asia. However, profitability faced pressure as net profit fell 16% to ₹137 crore, primarily due to inflationary input costs and a significant rise in tax expenses.

The Board of Directors met on August 4, 2026, to approve the unaudited financial results. The company highlighted that like-to-like domestic growth stood at 12%, with volume growth of 8%. Strategic investments, including the full consolidation of Axiom Ayurveda and the majority stake acquisition in IncNut Digital, contributed significantly to the domestic mix, accounting for approximately 18% of domestic business and growing 61% on a like-to-like basis.

Financial Performance

The quarter saw a divergence between revenue growth and profit margins. While EBITDA grew 6% to ₹226 crore, gross margins contracted by 360 basis points to 65.8% due to higher crude oil prices and packaging costs. Profit Before Tax (PBT) increased marginally by 4% to ₹195 crore. The decline in net profit was largely attributed to a jump in tax expense, which rose 148% year-on-year to ₹55.8 crore.

Segmental Breakdown

Domestic business remained the primary growth engine. Hair & Scalp Care delivered the strongest category performance with 11% growth, reaching ₹271 crore in net sales. Skin Care grew by 3% to ₹246 crore, while Health Care expanded by 2% to ₹232 crore. The Strategic Investments portfolio, comprising brands like The Man Company and Brillare, showed remarkable momentum with 61% like-to-like growth.

International Business declined 12% to ₹122 crore. Management cited supply-chain bottlenecks and the West Asia conflict as key headwinds. Despite this, the company implemented calibrated price increases in the MENAP region to mitigate inflationary pressures and focused on strengthening distribution productivity.

What the Numbers Show

A critical observation from the filing is the widening gap between operating profit and net profit. While EBITDA grew at 6%, net profit contracted by 16%. This divergence highlights the impact of non-operating factors, specifically the 148% surge in tax expense, which rose from ₹22.5 crore in Q1FY26 to ₹55.8 crore in Q1FY27. This suggests that despite disciplined cost management preserving EBITDA margins at 21.8%, the effective tax burden significantly eroded bottom-line returns in the quarter.

Strategic Initiatives and Outlook

Emami continued its channel transformation, with organised channels growing 19% and contributing 32% of domestic business. Quick Commerce now accounts for 35% of e-commerce sales. The company also made strategic moves to strengthen its portfolio, making Axiom Ayurveda a wholly-owned subsidiary and acquiring a majority stake in IncNut Digital to bolster its presence in the personalised beauty segment.

Looking ahead, management expressed optimism about Q2FY27, citing healthy demand trends and momentum in strategic investment businesses. Harsha V Agarwal, Vice Chairman and Managing Director, noted that digital and AI capabilities are becoming core enablers of their growth strategy. Mohan Goenka, Vice Chairman and Whole-Time Director, emphasized that as input cost pressures ease, the company is well-positioned to strengthen profitability while sustaining growth.